Dr. Amanda Collins is the Director of Digital Phenotyping and Therapeutics Research at the DCRP, and she is a Member of the Faculty in the Department of Psychiatry at Harvard Medical School. She completed her PhD in clinical psychology at Mississippi State University and her postdoctoral fellowship at Dartmouth College. Her research primarily focuses on reward dysfunction as a transdiagnostic mechanism underlying the etiology and maintenance of psychopathology. The two areas of her research focus on: (1) the application of advanced statistical methods to predict changes in psychopathology and (2) the development and testing of both in-person and digital interventions. She bridges these two areas of research by using advanced methods to understand what interventions work best and for whom, with the overall goal of developing more personalized interventions to treat reward dysfunction transdiagnostically. Dr. Collins' research has been supported by the National Institute on Drug Abuse to develop and evaluate digital interventions for co-occurring disorders.